TNNI3 and cardiovascular disorder: It has been reported that COVID-19 triggers an increase in the levels of blood biomarkers of cardiovascular diseases, particularly cTnI (Lippi et al., 2020; Shoar et al., 2020; Toraih et al., 2020; Ali et al., 2021; Haji et al., 2022), significantly reducing the life expectancy of the patient.